← Leaderboards
Michael E Selsted
University Of California Irvine
$14,431,563
Attributed
$17,083,561
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$17,083,561 · 8
By mechanism
R01$12,916,459 · 5
R37$3,703,661 · 1
P51$463,441 · 2
Top collaborators
- Andre J. Ouellette5 shared
Most similar at University Of California Irvine
Same institution · by research overlap
- Andre J. Ouellette$7,639,503
- James S Nowick$11,299,564
- Charles G Glabe$19,961,839
Others in their field
Top investigators on “Defensins”
- Aaron Weinberg · Case Western Reserve University$11,800,736
- Charles L Bevins · Cleveland Clinic Foundation$10,743,358
- Stanley Perlman · University Of Iowa$7,992,848
- Sunil K Ahuja · University Of Texas Hlth Sci Ctr San Ant$7,775,622
- Andre J. Ouellette · University Of California Irvine$7,620,503
- Betsy C. Herold · Children'S Hospital Med Ctr (Cincinnati)$7,080,941
Research focus
DefensinsPeptidesTheta-DefensinMonocyteHost DefenseLeukocytesMediatingPropertyDesignMacaca MulattaMacrophagePrimatesBaseResponsePrototypeInsightMolecularImmune ResponseElementsNeutrophilInfectionIn VitroPathogenResistance
Grant awards (37)
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections$899,573
R01 · FY2020 · AI · contact PI
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections$920,556
R01 · FY2019 · AI · contact PI
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections$945,797
R01 · FY2018 · AI · contact PI
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections$1,042,376
R01 · FY2017 · AI · contact PI
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections$1,495,694
R01 · FY2016 · AI · contact PI
Molecular Aspects of Leukocyte Antimicrobial Peptides$434,034
R01 · FY2016 · AI · contact PI
Molecular Aspects of Leukocyte Antimicrobial Peptides$433,925
R01 · FY2015 · AI · contact PI
Molecular Aspects of Leukocyte Antimicrobial Peptides$432,609
R01 · FY2014 · AI · contact PI
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins$388,922
R01 · FY2014 · DE · contact PI
Molecular Aspects of Leukocyte Antimicrobial Peptides$405,520
R01 · FY2013 · AI · contact PI
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins$373,365
R01 · FY2013 · DE · contact PI
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins$388,922
R01 · FY2012 · DE · contact PI
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins$381,065
R01 · FY2011 · DE · contact PI
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins$392,850
R01 · FY2010 · DE · contact PI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$315,628
R37 · FY2009 · AI · contact PI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$38,997
R37 · FY2009 · AI · contact PI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$354,625
R37 · FY2008 · AI · contact PI
Physiologic Peptide Cyclization in Myeloid Cells$354,625
R01 · FY2008 · AI · contact PI
MOLECULAR ONTOGENY OF ORAL MUCOSAL RESISTANCE TO SIV$306,788
P51 · FY2008 · RR · contact PI
Molecular Ontogeny of Oral Mucosal Resistance to SIV$573,264
R01 · FY2007 · DE · contact PI
Physiologic Peptide Cyclization in Myeloid Cells$361,494
R01 · FY2007 · AI · contact PI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$361,494
R37 · FY2007 · AI · contact PI
Molecular Ontogeny of Oral Mucosal Resistance to SIV$559,660
R01 · FY2006 · DE · contact PI
Physiologic Peptide Cyclization in Myeloid Cells$372,291
R01 · FY2006 · AI · contact PI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$372,291
R37 · FY2006 · AI · contact PI
MOLECULAR ONTOGENY OF ORAL MUCOSAL RESISTANCE TO SIV$156,653
P51 · FY2006 · RR · contact PI
Molecular Ontogeny of Oral Mucosal Resistance to SIV$519,559
R01 · FY2005 · DE
Physiologic Peptide Cyclization in Myeloid Cells$381,042
R01 · FY2005 · AI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$380,626
R37 · FY2005 · AI
Physiologic Peptide Cyclization in Myeloid Cells$26,441
R01 · FY2005 · AI
Molecular Ontogeny of Oral Mucosal Resistance to SIV$454,125
R01 · FY2004 · DE
Physiologic Peptide Cyclization in Myeloid Cells$378,750
R01 · FY2004 · AI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$376,000
R37 · FY2004 · AI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$376,000
R37 · FY2003 · AI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$376,000
R37 · FY2002 · AI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$376,000
R37 · FY2001 · AI
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES$376,000
R37 · FY2000 · AI